Global Functional Electrical Stimulation Market to Grow with a CAGR of ~8.5% During 2022-2031; Market to Grow on Account of the Increasing Prevalence of Paralysis and Technological Advancement in the Healthcare Sector

Key Companies Covered in the Global Functional Electrical Stimulation Market Research Report by Research Nester Are Abbot Laboratories, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Novartis International AG, F. Hoffmann-La Roche AG, Eli Lily and Company, and other key market players.


New York, June 22, 2022 (GLOBE NEWSWIRE) -- As Per World Health Organization, every year, between 250000 to 500000 persons suffer a spinal cord injury in the world. Functional electrical stimulation (FES) is a technology that uses low-energy electrical pulses to induce artificial bodily movements in people who have spinal cord injury, paralysis, or whose central nervous system is injured. Although there is no credible estimate of global prevalence, the annual global incidence is believed to be 40 to 80 cases per million people, and every year around 6.8 million people die on account of neurological disorders.

Research Nester has published a detailed market report on ‘Global Functional Electrical Stimulation Market’ for the forecast period of 2022 – 2031 which includes the ongoing industry innovations and recent trends being adopted by the major industry players to achieve their business targets. Apart from that, the inclusive data on market size, growth rate, market revenue share, growth opportunities and challenges for the market players along with worldwide analysis on five major regions – North America, Latin America, Europe, Asia Pacific and Middle East & Africa has been provided in the report.

According to World Health Organization, every year around 1.71 billion people suffer from musculoskeletal issues, with 568 million of those suffering from lower back pain, and up to 1 billion people get affected by neurological disorders. The market growth is projected to grow based on the increasing prevalence of musculoskeletal and central nervous system illnesses, which are the leading causes of paralysis. Furthermore, as more advanced technology is implemented in the healthcare industry, the market is predicted to grow over the forecast period. The global functional electrical stimulation market is estimated to grow at a CAGR of ~8.5% over the forecast period of 2022–2031.

Get a sample copy of the report@ https://www.researchnester.com/sample-request-3949

On the basis of geographical analysis, the global functional electrical stimulation market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. Out of these, the market in North America region is expected to hold the largest market share over the forecast period on account of the rising prevalence of paralysis in the region. According to National Organization for Rare Disorders, in the United State, every year around 25,000 people gets affected by muscle dystrophy. In addition to this, the technological advancement in the medical industry is likely to drive market growth over the projected period.

The market in the Asia Pacific region is estimated to witness significant market growth over the forecast period owing to the increasing burden of neurological diseases which is causing partial or full paralysis. For instance, in 2019, 64.4 million people in southeast Asia, and 85 million people in western pacific regions were diagnosed with neurological disorders. However, the increasing awareness amongst the people and improving healthcare facilities in the region are likely to drive market growth over the estimated time period.

Click here to get the short-term and long-term impacts of COVID-19 on this Market. Please visit: https://www.researchnester.com/reports/functional-electrical-stimulation-market/3949

The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

The global functional electrical stimulation market is segmented by indication into neurological disorders, pain management, musculoskeletal disorders, and others. Out of these, the neurological disorders segment is expected to grow at a significant CAGR over the forecast period on account of an increasing number of cases of central nervous system failure, most of which are caused by accidents or damage to the spinal cord. As per the World Health Organization, every year, around 1.3 million people's lives are ended prematurely as a result of a traffic accident. Non-fatal injuries affect between 20 and 50 million more people, with many of them resulting in paralysis as a result of their injury. Additionally, some disorders, namely cancer, can migrate to the spinal cord or brain, resulting in paralysis.

Get a Sample PDF of Functional Electrical Stimulation Market Report 2022

Further, the global functional electrical stimulation market is segmented by end-user into hospitals, clinics, ambulatory health center, and others. Out of these, the hospitals segment is estimated to cover the maximum market share over the forecast period owing to the rising cases of paralysis and increasing spending on healthcare as people are becoming more aware of the health and spinal cord related diseases. As per the record by World Health Organization, more than 930 million people spend 10% of their household income on healthcare. Further, the technological advancement in the healthcare sector is likely to propel market growth in the near future.

The global functional electrical stimulation market is also segmented on the basis of product type.

Global Functional Electrical Stimulation Market Segmentation by Product Type

  • Wired Devices
  • Wireless Devices
  • Others

For more insights on the market share of various regions Request for a FREE sample now!

Some of the prominent key players and their company profiling mentioned in the report include Abbot Laboratories, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Novartis International AG, F. Hoffmann-La Roche AG, Eli Lily and Company, and other key market players. The profiling enfolds growth opportunities, challenges, and market trends prevalent in the market.

Explore Our Recent Related Reports:

Closed System Transfer Devices (CSTD) Market Segmentation by Type (Membrane-to-Membrane, and Needleless); by Technology (Diaphragm based, Compartmentalized, Filtration, and Others); and by End User (Hospitals & Clinics, Oncology Centers, and Others) – Global Demand Analysis & Opportunity Outlook 2031
Repositioning and Offloading Devices Market Segmentation by Product Type (Patients Turning & Positioning Systems, Replacement Sheet, Pressure Relief Mattresses, and Others); and by End User (Hospitals, Ambulatory Surgery Centers, and Skill Nursing Facilities) – Global Demand Analysis & Opportunity Outlook 2031
Ultrasound Devices Market Segmentation by Application (Radiology, Gynecology, Cardiology, Urology, and Vascular); by Technology (2D Ultrasound Imaging, 3D and 4D Ultrasound Imaging, Doppler Imaging, and High-intensity Focused Ultrasound); and by End-User (Hospitals, Clinical Centers, and Research Centers) – Global Demand Analysis & Opportunity Outlook 2031
IV Disinfecting Caps Market Segmentation by Product Type (Single Cap, and Double Cap); by Application (Blood Transfusion, Blood Collection, and Infusion); and by End-User (Hospitals, Clinics, and Diagnostic Centers) – Global Demand Analysis & Opportunity Outlook 2031
Automated Cell Culture Market Segmentation by Product (Consumables, and Equipment); by Application (Biopharmaceutical Production, Tissue Engineering & Regenerative Medicine, Drug Screening & Development, Gene Therapy, Stem Cell Research, Diagnostics, Toxicity Testing, and Others); and by End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Others) – Global Demand Analysis & Opportunity Outlook 2021-2031

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

For More Update Follow: - LinkedIn | Twitter | Facebook | Xing